These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10930590)
21. Trophic factors in cerebrospinal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease. Albrecht D; GarcĂa L; Cartier L; Kettlun AM; Vergara C; Collados L; Valenzuela MA AIDS Res Hum Retroviruses; 2006 Mar; 22(3):248-54. PubMed ID: 16545011 [TBL] [Abstract][Full Text] [Related]
22. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). Osame M J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162 [TBL] [Abstract][Full Text] [Related]
23. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)]. Yamano Y; Sato T Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097 [TBL] [Abstract][Full Text] [Related]
24. Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Matsuura E; Kubota R; Tanaka Y; Takashima H; Izumo S J Neuropathol Exp Neurol; 2015 Jan; 74(1):2-14. PubMed ID: 25470342 [TBL] [Abstract][Full Text] [Related]
25. Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study. Godoy AJ; Kira J; Hasuo K; Goto I J Neurol Sci; 1995 Nov; 133(1-2):102-11. PubMed ID: 8583211 [TBL] [Abstract][Full Text] [Related]
26. HAM/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings. Puccioni-Sohler M; Gasparetto E; Cabral-Castro MJ; Slatter C; Vidal CM; Cortes RD; Rosen BR; Mainero C Arq Neuropsiquiatr; 2012 Apr; 70(4):246-51. PubMed ID: 22510735 [TBL] [Abstract][Full Text] [Related]
27. Widespread active inflammatory lesions in a case of HTLV-I-associated myelopathy lasting 29 years. Iwasaki Y; Sawada K; Aiba I; Mukai E; Yoshida M; Hashizume Y; Sobue G Acta Neuropathol; 2004 Dec; 108(6):546-51. PubMed ID: 15372282 [TBL] [Abstract][Full Text] [Related]
28. Immunoreactivity of beta-amyloid precursor protein in amyotrophic lateral sclerosis. Sasaki S; Iwata M Acta Neuropathol; 1999 May; 97(5):463-8. PubMed ID: 10334483 [TBL] [Abstract][Full Text] [Related]
29. MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy. Ogata A; Nagashima K; Tashiro K; Miyakawa A; Mikuni C J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):194-6. PubMed ID: 8437009 [TBL] [Abstract][Full Text] [Related]
30. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression. Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430 [TBL] [Abstract][Full Text] [Related]
31. Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). Yoshioka A; Hirose G; Ueda Y; Nishimura Y; Sakai K J Neurol Neurosurg Psychiatry; 1993 Sep; 56(9):1004-7. PubMed ID: 8410023 [TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. Umehara F; Izumo S; Nakagawa M; Ronquillo AT; Takahashi K; Matsumuro K; Sato E; Osame M J Neuropathol Exp Neurol; 1993 Jul; 52(4):424-30. PubMed ID: 8355031 [TBL] [Abstract][Full Text] [Related]
33. [Rat model of HTLV-I infection--ultrastructural study of HAM rat disease]. Abe M Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1399-408. PubMed ID: 7705750 [TBL] [Abstract][Full Text] [Related]
35. [Analysis of HAM rat disease with HTLV-I infection, an animal model for HAM/TSP in human-immunohistochemical, immuno-electron microscopic and flow cytometrical analyses of microglia/macrophages in the affected spinal cord]. Morita K Hokkaido Igaku Zasshi; 1998 May; 73(3):253-74. PubMed ID: 9719951 [TBL] [Abstract][Full Text] [Related]
38. A neuropathological study of paraparetic rats injected with HTLV-I-producing T cells. Mizusawa H; Kushida S; Matsumura M; Tanaka H; Ami Y; Hori M; Kobayashi M; Uchida K; Yagami K; Yoshizawa T J Neurol Sci; 1994 Nov; 126(2):101-8. PubMed ID: 7853013 [TBL] [Abstract][Full Text] [Related]
39. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Jernigan M; Morcos Y; Lee SM; Dohan FC; Raine C; Levin MC Neurology; 2003 Apr; 60(8):1320-7. PubMed ID: 12707436 [TBL] [Abstract][Full Text] [Related]
40. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon. Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]